Showing results (311-320 of 541) with videos related to

Sort By:
Pageof 55
Plos One|November 3, 2011
Hepatitis B virus impairs TLR9 expression and function in plasmacytoid dendritic cellsIsabelle E Vincent, Claudia Zannetti, Julie Lucifora, et al.
Virology|August 28, 2012
In vivo electroporation improves therapeutic potency of a DNA vaccine targeting hepadnaviral proteinsGhada Khawaja, Thierry Buronfosse, Catherine Jamard, et al.
Gastroenterology|February 5, 2008
Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approachJean-Michel Pawlotsky, Geoffrey Dusheiko, Angelos Hatzakis, et al.
Hepatitis Monthly|October 27, 2015
Increased Ribavirin Bioavailability Associated With Telaprevir Use in Hepatitis C Patients Treated With PEGylated -Interferon/Ribavirin/Telaprevir Triple TherapyPierre Pradat, Victor Virlogeux, Marianne Maynard, et al.
The Journal of General Virology|November 1, 2015
FIG4 is a hepatitis C virus particle-bound protein implicated in virion morphogenesis and infectivity with cholesteryl ester modulation potentialJessica Cottarel, Marie-Laure Plissonnier, Majlinda Kullolli, et al.
Journal of Hepatology|November 8, 2025
Safety and efficacy of REP 2139-Mg in patients with HDV-related advanced liver disease in an international compassionate access programChristiane Stern, Véronique Loustaud-Ratti, Cihan Yurdaydin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 18, 2008
Adefovir dipivoxil is effective for the treatment of cirrhotic patients with lamivudine failureFabien Zoulim, Parviz Parvaz, Patrick Marcellin, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 6, 2005
Benefit of sustained virological response to combination therapy on graft survival of liver transplanted patients with recurrent chronic hepatitis CThierry Bizollon, Pierre Pradat, Jean-Yves Mabrut, et al.
BMC Infectious Diseases|March 22, 2014
Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patientsGiorgiana Hatu, François Bailly, Emmanuel Pourcelot, et al.
Oncogene|December 4, 2003
Adenosine deaminase, a key enzyme in DNA precursors control, is a new p73 targetApollonia Tullo, Giuseppe Mastropasqua, Jean Christophe Bourdon, et al.
Pageof 55